Invictus Signs Definitive Agreement with Clinic Servicing 3,400 ACMPR Registered Patients

Invictus (TSXV:GENE, OTC:IVITF, FRA: 8IS1) ("Invictus" or the "Company") is pleased to announce that it has entered into a definitive agreement...

Invictus Provides Update on German Partnership and EU-GMP Certification

Invictus (TSXV:GENE, OTC:IVITF) is pleased to provide an update on its progress towards European Union Good Manufacturing Practices ("EU-GMP") certification.